Skip to content
StockMarketAgent
Sector pending / Commercial Physical and Biological ResearchUpdated 2026-05-10 22:07 UTC

FRA/01P stock hub

FRA/01P has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/01Pis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
10.3B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/01P
In the news

Latest news · FRA/01P

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24
P25 n/aP50 n/aP75 n/a
Trailing P/E25.8
P25 n/aP50 n/aP75 n/a
ROE77.3
P25 n/aP50 n/aP75 n/a
ROIC475.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/01P market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
207
Groups with data
11
Currency
USD
Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
6,300
Employees Change
300%
Employees Change Percent
5.08
Enterprise value
EUR 9.9B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Commercial Physical and Biological Research
Last refreshed
2026-05-10
Market cap
EUR 10.3B
Price
EUR 358
Price currency
EUR
Rev Per Employee
368,708.23x
Sic
8731
Symbol
fra/01P
Website
https://www.medpace.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.88%
EV Earnings
24.69x
EV/EBIT
20.61x
EV/EBITDA
18.29x
EV/FCF
15.99x
EV/Sales
4.33x
FCF yield
5.99%
Forward P/E
24.01x
P/B ratio
19.83x
P/E ratio
25.77x
P/S ratio
4.43x
PE Ratio10 Y
39.58x
PE Ratio3 Y
30.06x
PE Ratio5 Y
29.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
21.02%
EBITDA Margin
22.07%
FCF margin
26.55%
Gross margin
71.9%
Gross Profit
EUR 1.7B
Gross Profit Growth
31.16%
Gross Profit Growth Q
33.51%
Gross Profit Growth3 Y
24.3%
Gross Profit Growth5 Y
26.78%
Net Income
EUR 399.3M
Net Income Growth
10.57%
Net Income Growth Q
8.09%
Net Income Growth3 Y
21.49%
Net Income Growth5 Y
23.66%
Pretax Margin
21.35%
Profit Margin
17.19%
Profit Per Employee
EUR 63,381
ROA
17.47
Roa5y
12.99
ROCE
71.75
ROE
77.25
Roe5y
49.16
ROIC
475.6
Roic5y
87.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
35.91%
Cagr3y
24.33%
Cagr5y
21.64%
EPS Growth
21.48
EPS Growth Q
16.62
EPS Growth3 Y
26.43
EPS Growth5 Y
30.37
FCF Growth
31.44%
FCF Growth Q
25.15%
FCF Growth3 Y
22.72%
FCF Growth5 Y
24.83%
OCF Growth
27.01%
OCF Growth Q
20.62%
OCF Growth10 Y
22.94%
OCF Growth3 Y
20.56%
OCF Growth5 Y
22.6%
Revenue Growth
24.19x
Revenue Growth Q
26.5x
Revenue Growth3 Y
19.66x
Revenue Growth5 Y
22.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 1.33
Assets
EUR 1.8B
Cash
EUR 566.1M
Current Assets
EUR 965.9M
Current Liabilities
EUR 1.1B
Debt
EUR 126.7M
Debt EBITDA
EUR 0.23
Debt Equity
EUR 0.24
Debt FCF
EUR 0.21
Equity
EUR 518.9M
Liabilities
EUR 1.3B
Long Term Assets
EUR 881.1M
Long Term Liabilities
EUR 187.6M
Net Cash
EUR 439.4M
Net Cash By Market Cap
EUR 4.27
Net Cash Growth
74.03%
Net Debt EBITDA
EUR -0.86
Net Debt Equity
EUR -0.85
Net Debt FCF
EUR -0.71
Tangible Book Value
EUR -84.4M
Tangible Book Value Per Share
EUR -2.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.85
Net Working Capital
EUR -724M
Quick ratio
0.78
Working Capital
EUR -178.6M
Working Capital Turnover
EUR -9.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
8.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
35.88%
200-day SMA
438.4
3Y total return
92.19%
50-day SMA
397.6
50-day SMA vs 200-day SMA
50under200
5Y total return
166.22%
All Time High
558.2
All Time High Change
-35.61%
All Time High Date
2025-10-23
All Time Low
19.95
All Time Low Change
1,701.77%
All Time Low Date
2017-05-03
ATR
16.09
Ch YTD
-25.23
High
361.1
High52
558.2
High52 Date
2025-10-23
High52ch
-35.85%
Low
358.1
Low52
252.9
Low52 Date
2025-05-23
Low52ch
41.6%
Ma50ch
-9.62%
Price vs 200-day SMA
-18.02%
RSI
38.8
RSI Monthly
50.05
RSI Weekly
40.58
Sharpe ratio
0.7x
Sortino ratio
1.46
Total Return
8.94%
Tr YTD
-25.23
Tr1m
-17.76%
Tr1w
1.38%
Tr3m
-21.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 488.2M
Operating Income Growth
23.36
Operating Income Growth Q
24.65
Operating Income Growth3 Y
23.25
Operating Income Growth5 Y
25.73
Operating margin
21.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
22,996,450%
Shares Insiders
19.42%
Shares Institutions
85.27%
Shares Qo Q
-0.01%
Shares Yo Y
-8.94%
Short Ratio
3.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
EUR 596.9M
Average Volume
12.55x
Bv Per Share
18.17
CAPEX
EUR -24.4M
Ch1m
-17.76
Ch1w
1.38
Ch1y
35.88
Ch3m
-21.58
Ch3y
92.19
Ch5y
166.2
Ch6m
-28.97
Change
-1.4%
Change From Open
-0.11
Close
363.2
Days Gap
-1.29
Depreciation Amortization
23,827,732.2
Dollar Volume
8,236.3
Earnings Date
2026-04-22
EBIT
EUR 488.2M
EBITDA
EUR 512.6M
EPS
EUR 13.79
F Score
7
FCF
EUR 616.6M
FCF EV Yield
6.26x
Financing CF
-435,169,510
Fiscal Year End
December
Founded
1,992
Goodwill
561,686,637
Graham Number
75.15578
Graham Upside
-79.01
Income Tax
EUR 96.6M
Investing CF
-24,198,537
Is Primary Listing
0
Last Earnings Date
2026-04-22
Last Report Date
2026-03-31
Lynch Fair Value
EUR 329
Lynch Upside
-8.17
Ma150
451
Ma150ch
-20.31%
Ma20
391.2
Ma20ch
-8.12%
Net CF
183,212,789
Open
358.5
P FCF Ratio
16.68
P OCF Ratio
16.05
Position In Range
0
Ppne
223,319,272.3
Price Date
2026-05-08
Price EBITDA
EUR 20.07
Relative Volume
1.83x
Revenue
2,322,861,836x
SBC By Revenue
0.85x
Share Based Comp
19,784,848
Tax By Revenue
4.16x
Tax Rate
19.48%
Tr6m
-28.97%
Volume
23
Z Score
6.84
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/01P pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/01P stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+35.9%
S&P 500 1Y: n/a
3Y total return
+92.2%
S&P 500 3Y: n/a
5Y total return
+166.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/01P?

Insider, institutional, and short-interest positioning.

Institutional ownership
+85.3%
Share of float held by funds and institutions
Insider ownership
+19.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.2 days to cover
Y/Y dilution
-8.9%
Negative means the company is buying back shares.
Technical

FRA/01P momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.8
Neutral momentum band
Price vs 200-day MA
-18.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.70
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/01P

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/01P stock rating?

fra/01P is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/01P analysis?

The full report lives at /stocks/fra/01P/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/01P?

The latest report frames fra/01P around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/01P page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/01P stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario